GW Pharmaceuticals stock leapt higher Friday after European officials adopted a positive opinion of its CBD oil seizure treatment, a drug to be sold under the brand name Epidyolex. Read More...
This Biotech Stock Flew Higher On Likely CBD Oil Approval in Europe
GW Pharmaceuticals stock leapt higher Friday after European officials adopted a positive opinion of its CBD oil seizure treatment, a drug to be sold under the brand name Epidyolex.
Add Comment